Detalhe da pesquisa
1.
Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer.
Prostate
; 84(2): 177-184, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846041
2.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE.
Endocr Pract
; 26(Suppl 1): 1-46, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32427503
3.
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.
J Oral Maxillofac Surg
; 70(12): 2768-75, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22330331
4.
Vertebral Fractures After Denosumab Discontinuation in Breast Cancer Survivors: A Single Institution Experience.
HSS J
; 17(2): 185-191, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34421429
5.
Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
Oncologist
; 13(8): 911-20, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18695259
6.
Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.
J Craniomaxillofac Surg
; 44(3): 265-70, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26782845
7.
Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone.
Ann N Y Acad Sci
; 1218: 80-7, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20946577
8.
Osteonecrosis of the jaw related to bevacizumab.
J Clin Oncol
; 26(24): 4037-8, 2008 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18711196